Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana

被引:10
作者
Yawson, Abena Ahwianfoa [2 ]
Abekah-Nkrumah, Gordon [1 ]
Okai, Grace Adjei [2 ]
Ofori, Charles Gyamfi [3 ]
机构
[1] Univ Ghana, Dept Publ Adm & Hlth Serv Management, Business Sch, POB LG 78, Legon, Ghana
[2] Univ Ghana, Dept Publ Adm & Hlth Serv Management, Business Sch, Accra, Ghana
[3] Univ Ghana, Dept Finance, Business Sch, Accra, Ghana
关键词
adverse drug reaction; attitude; drug safety; healthcare professionals; pharmacovigilance;
D O I
10.1177/20420986221116468
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Spontaneous reporting systems are the commonest means of reporting adverse drug reactions (ADRs) worldwide. Under-reporting remains a challenge particularly in developing countries among healthcare professionals (HCPs) who are considered the primary stakeholders in the reporting of ADRs. The challenge with studies in countries such as Ghana is that the focus has been on a single professional group or health facility. This study examines the rate of reporting as well as awareness, knowledge, and attitudes toward ADR reporting across professional groups (doctors, nurses, and pharmacist) and selected health facilities (ownership types: government, quasi-government, and private; hierarchy: district, regional, and teaching) in Ghana. Method: A cross-sectional survey was conducted to select and interview 424 healthcare professionals (HCPs) from 8 hospitals in the Greater Accra and Eastern regions of Ghana on issues of ADR reporting, awareness, knowledge, and attitudes toward ADR reporting. Valid responses from 378 HCPs were obtained and analyzed using frequencies and percentages. Findings: The results suggest that about 82.8% of the HCPs interviewed have come across an ADR incidence, but only 52.6% of them have reported such incidence, with pharmacist (66.7%) being the most likely to report. The results further suggest that about 85.8% of HCPs are aware of ADR reporting procedures and display positive attitudes toward same. In addition, the knowledge of HCPs on ADR reporting is low with training being a major area of need. Conclusion: There is the need for healthcare managers and the regulator to pay attention to existing gaps in awareness, attitudes, and most importantly knowledge of HCPs on structures and modalities for ADR reporting.
引用
收藏
页数:15
相关论文
共 40 条
[1]  
Aagaard L, 2012, DRUG SAFETY, V35, P1171, DOI 10.2165/11631940-000000000-00000
[2]   Factors affecting patient reporting of adverse drug reactions: a systematic review [J].
Al Dweik, Rania ;
Stacey, Dawn ;
Kohen, Dafna ;
Yaya, Sanni .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (04) :875-883
[3]  
Amedome SN., 2017, J PHARMA, V5, P229
[4]   Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBaseA® [J].
Ampadu, Haggar H. ;
Hoekman, Jarno ;
de Bruin, Marieke L. ;
Pal, Shanthi N. ;
Olsson, Sten ;
Sartori, Daniele ;
Leufkens, Hubert G. M. ;
Dodoo, Alexander N. O. .
DRUG SAFETY, 2016, 39 (04) :335-345
[5]  
[Anonymous], 2017, Guideline on good pharmacovigilance practices (GVP) (EMA/876333/2011 Rev. 4)
[6]  
[Anonymous], 2002, Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions: Why Health Professionals Need to Take Action
[7]   Under-reporting of serious adverse drug reactions in Sweden [J].
Bäckström, M ;
Mjörndal, T ;
Dahlqvist, R .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (07) :483-487
[8]   An agenda for UK clinical pharmacology Pharmacovigilance [J].
Edwards, I. Ralph .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) :979-982
[9]  
Elbe D, 2010, J CAN ACAD CHILD ADO, V19, P40
[10]  
Food and Drugs Authority, 2018, DRUGLENS, V6, P1